BG49717A3 - METHOD OF OBTAINING HIRUDIN - Google Patents
METHOD OF OBTAINING HIRUDINInfo
- Publication number
- BG49717A3 BG49717A3 BG077615A BG7761586A BG49717A3 BG 49717 A3 BG49717 A3 BG 49717A3 BG 077615 A BG077615 A BG 077615A BG 7761586 A BG7761586 A BG 7761586A BG 49717 A3 BG49717 A3 BG 49717A3
- Authority
- BG
- Bulgaria
- Prior art keywords
- hirudin
- mature
- obtaining
- obtaining hirudin
- yeast
- Prior art date
Links
- 102000007625 Hirudins Human genes 0.000 title abstract 4
- 108010007267 Hirudins Proteins 0.000 title abstract 4
- WQPDUTSPKFMPDP-OUMQNGNKSA-N hirudin Chemical compound C([C@@H](C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC=1C=CC(OS(O)(=O)=O)=CC=1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(O)=O)NC(=O)[C@H](CC(O)=O)NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC=1NC=NC=1)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CCCCN)NC(=O)[C@H]1N(CCC1)C(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H]1NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(O)=O)NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H]([C@@H](C)CC)NC(=O)[C@@H]2CSSC[C@@H](C(=O)N[C@@H](CCC(O)=O)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N[C@H](C(NCC(=O)N[C@@H](CCC(N)=O)C(=O)NCC(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N2)=O)CSSC1)C(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H]1NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)CNC(=O)[C@H](CO)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@@H](NC(=O)[C@H](CC=2C=CC(O)=CC=2)NC(=O)[C@@H](NC(=O)[C@@H](N)C(C)C)C(C)C)[C@@H](C)O)CSSC1)C(C)C)[C@@H](C)O)[C@@H](C)O)C1=CC=CC=C1 WQPDUTSPKFMPDP-OUMQNGNKSA-N 0.000 title abstract 4
- 229940006607 hirudin Drugs 0.000 title abstract 4
- 238000000034 method Methods 0.000 title abstract 2
- 240000004808 Saccharomyces cerevisiae Species 0.000 abstract 1
- 239000003146 anticoagulant agent Substances 0.000 abstract 1
- 229940127219 anticoagulant drug Drugs 0.000 abstract 1
- 238000000338 in vitro Methods 0.000 abstract 1
- 239000013612 plasmid Substances 0.000 abstract 1
- 239000000126 substance Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/81—Protease inhibitors
- C07K14/815—Protease inhibitors from leeches, e.g. hirudin, eglin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/37—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from fungi
- C07K14/39—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from fungi from yeasts
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/37—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from fungi
- C07K14/39—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from fungi from yeasts
- C07K14/395—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from fungi from yeasts from Saccharomyces
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/80—Vectors or expression systems specially adapted for eukaryotic hosts for fungi
- C12N15/81—Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
- C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Mycology (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Microbiology (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Physics & Mathematics (AREA)
- Plant Pathology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Tropical Medicine & Parasitology (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Instructional Devices (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Yarns And Mechanical Finishing Of Yarns Or Ropes (AREA)
Abstract
Антикоагулантът хирудин се използва за нуждите на медицинската практика. Той е висококачествен продукт с висок добив. По метода дрожди се трансформират от плазмид, съдържащ функционален блок на днк, кодиращ хирудин, като полученият продукт се извлича в зряла форма или под формата на хирудиново вещество, което може да зрее ин витро. 21 претенцииThe anticoagulant hirudin is used for the needs of medical practice. It is a high quality product with high yield. In the method, yeast is transformed from a plasmid containing a functional block of DNA encoding hirudin, and the resulting product is extracted in a mature form or in the form of a hirudin substance that can mature in vitro. 21 claims
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR8506672A FR2593518B1 (en) | 1985-05-02 | 1985-05-02 | VECTORS FOR THE EXPRESSION AND SECRETION OF HIRUDIN BY TRANSFORMED YEASTS |
| PCT/FR1986/000153 WO1986006406A1 (en) | 1985-05-02 | 1986-05-02 | Vectors for the expression and secretion of hirudin by transformed yeasts |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BG49717A3 true BG49717A3 (en) | 1992-01-15 |
Family
ID=9318888
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BG077615A BG49717A3 (en) | 1985-05-02 | 1986-12-19 | METHOD OF OBTAINING HIRUDIN |
Country Status (22)
| Country | Link |
|---|---|
| EP (1) | EP0200655B1 (en) |
| JP (2) | JP2580141B2 (en) |
| KR (1) | KR870700234A (en) |
| AT (1) | ATE121778T1 (en) |
| AU (1) | AU600667B2 (en) |
| BG (1) | BG49717A3 (en) |
| CA (1) | CA1341501C (en) |
| CZ (1) | CZ282928B6 (en) |
| DE (1) | DE3650306T2 (en) |
| DK (1) | DK174837B1 (en) |
| ES (1) | ES8703930A1 (en) |
| FI (1) | FI104635B (en) |
| FR (2) | FR2593518B1 (en) |
| HU (1) | HU202919B (en) |
| IE (1) | IE67136B1 (en) |
| MC (1) | MC1785A1 (en) |
| NO (1) | NO302375B1 (en) |
| PL (1) | PL155074B1 (en) |
| PT (1) | PT82490B (en) |
| RU (1) | RU1774950C (en) |
| WO (1) | WO1986006406A1 (en) |
| ZA (1) | ZA863261B (en) |
Families Citing this family (34)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3738541A1 (en) * | 1987-11-13 | 1989-05-24 | Hoechst Ag | METHOD FOR INSULATING AND CLEANING HIRUDINE |
| FR2593518B1 (en) * | 1985-05-02 | 1989-09-08 | Transgene Sa | VECTORS FOR THE EXPRESSION AND SECRETION OF HIRUDIN BY TRANSFORMED YEASTS |
| MY101203A (en) * | 1985-12-12 | 1991-08-17 | Ucp Gen Pharma Ag | Production of thrombin iinhibitors. |
| GB8530631D0 (en) | 1985-12-12 | 1986-01-22 | Ciba Geigy Ag | Thrombin inhibitors |
| MC1834A1 (en) * | 1986-07-10 | 1988-06-03 | Transgene Sa | DNA FUNCTIONAL BLOCK AND PLASMID ENCODING HIRUDINE, TRANSFORMED YEAST, PROCESS FOR PREPARING HIRUDINE, HIRUDINE OBTAINED AND ITS USE |
| FR2607516B2 (en) * | 1986-12-01 | 1989-12-22 | Transgene Sa | IMPROVED VECTORS FOR EXPRESSING A HIRUDIN VARIANT IN YEAST, PROCESS AND PRODUCT OBTAINED |
| FR2607517B2 (en) * | 1986-12-01 | 1989-12-22 | Transgene Sa | VECTORS FOR EXPRESSING HIRUDIN VARIANTS IN YEAST, PROCESS AND PRODUCT OBTAINED |
| FR2611723B1 (en) * | 1987-02-27 | 1989-09-08 | Transgene Sa | RECOMBINANT DNA EXPRESSION VECTOR ENCODING HIRUDINE, INFECTED OR TRANSFORMED MAMMALIAN CELL CULTURES, PROCESS FOR PREPARING HIRUDINE AND PROTEIN OBTAINED |
| WO1988010299A1 (en) * | 1987-06-24 | 1988-12-29 | Novo-Nordisk A/S | A process for preparing a protein or polypeptide, a dna sequence coding for the polypeptide, a microorganism containing the dna sequence as well as the polypeptide and its use as a pharmaceutical preparation |
| US5256559A (en) * | 1988-03-04 | 1993-10-26 | Biogen, Inc. | Methods and compositions for inhibiting platelet aggregation |
| DE3819079A1 (en) * | 1988-06-04 | 1989-12-07 | Hoechst Ag | HIRUDINE DERIVATIVES WITH DELAYED EFFECT |
| WO1990001063A1 (en) * | 1988-07-23 | 1990-02-08 | Delta Biotechnology Limited | New secretory leader sequences |
| DE3835815A1 (en) * | 1988-10-21 | 1990-04-26 | Hoechst Ag | NEW ISOHIRUDINE |
| US5053453A (en) * | 1988-11-01 | 1991-10-01 | Baxter International Inc. | Thromboresistant materials and methods for making same |
| CA2000887A1 (en) * | 1988-11-01 | 1990-05-01 | Cecilia S.L. Ku | Thromboresistant materials and methods for making same |
| FR2646437B1 (en) * | 1989-04-28 | 1991-08-30 | Transgene Sa | NOVEL DNA SEQUENCES, THEIR APPLICATION AS A SEQUENCE ENCODING A SIGNAL PEPTIDE FOR THE SECRETION OF MATURE PROTEINS BY RECOMBINANT YEASTS, EXPRESSION CASSETTES, PROCESSED YEASTS AND PROCESS FOR PREPARING THE SAME |
| DE4009268A1 (en) * | 1990-03-22 | 1991-09-26 | Consortium Elektrochem Ind | SECRETION OF HIRUDIN DERIVATIVES |
| US6514730B1 (en) | 1991-03-21 | 2003-02-04 | Consortium für elektrochemische Industrie GmbH | Secretion of hirudin derivatives |
| US5837808A (en) * | 1991-08-20 | 1998-11-17 | Baxter International Inc. | Analogs of hirudin |
| DE4140381A1 (en) * | 1991-12-07 | 1993-06-09 | Hoechst Ag, 6230 Frankfurt, De | NEW SYNTHETIC ISOHIRUDINE WITH IMPROVED STABILITY |
| SG49859A1 (en) * | 1992-09-04 | 2002-03-19 | Ucp Gen Pharma Ag | Process for the production of protease inhibitors |
| US6500645B1 (en) | 1994-06-17 | 2002-12-31 | Novo Nordisk A/S | N-terminally extended proteins expressed in yeast |
| ZA954983B (en) * | 1994-06-17 | 1996-02-14 | Novo Nordisk As | N-terminally extended proteins expressed in yeast |
| DE19529997C1 (en) | 1995-08-16 | 1997-04-10 | Hoechst Ag | A method for inactivating carboxypeptidase Y in hirudin-containing culture broths |
| DE19543737A1 (en) * | 1995-11-24 | 1997-05-28 | Hoechst Ag | Process for the ultrafiltration of biological matrices containing peptides or proteins |
| DE19544233A1 (en) * | 1995-11-28 | 1997-06-05 | Hoechst Ag | Process for using the yeast ADH II promoter system for the biotechnological production of heterologous proteins in high yields |
| ZA9610456B (en) * | 1995-12-20 | 1997-06-20 | Novo Nordisk As | N-terminally extended proteins expressed in yeast |
| DE69625623T2 (en) | 1996-01-31 | 2003-11-06 | Sumitomo Bakelite Co. Ltd., Tokio/Tokyo | Method of manufacturing semiconductor device encapsulated in epoxy resin |
| US6265204B1 (en) * | 1997-01-17 | 2001-07-24 | Genencor International, Inc. | DNA sequences, vectors, and fusion polypeptides for secretion of polypeptides in filamentous fungi |
| US7202059B2 (en) | 2001-02-20 | 2007-04-10 | Sanofi-Aventis Deutschland Gmbh | Fusion proteins capable of being secreted into a fermentation medium |
| US7638618B2 (en) | 2001-02-20 | 2009-12-29 | Sanofi-Aventis Deutschland Gmbh | Nucleic acids encoding a hirudin and pro-insulin as superscretable peptides and for parallel improvement of the exported forms of one or more polypeptides of interest |
| DE10149678A1 (en) | 2001-10-09 | 2009-03-12 | Novel Science International Gmbh | New peptide compounds containing upto 6 aminoacid residues, are potent and specific thrombin inhibitors used for treating and diagnosing diseases associated with thrombin |
| DE10301255A1 (en) | 2003-01-15 | 2004-07-29 | Cpi Creative Pharma International Gmbh | Organic compounds with biological action as thrombin inhibitors and their use |
| US7795205B2 (en) | 2004-04-12 | 2010-09-14 | Canyon Pharmaceuticals, Inc. | Methods for effecting regression of tumor mass and size in a metastasized pancreatic tumor |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3382547D1 (en) * | 1983-01-12 | 1992-05-27 | Chiron Corp | SECRETORIC EXPRESSION IN EUKARYOTS. |
| AU572125B2 (en) * | 1983-03-17 | 1988-05-05 | Mabco Limited | Monoclonal antibodies with specificity for crosslinked fibrin and their diagnotic uses |
| JPS60501140A (en) * | 1983-04-22 | 1985-07-25 | アムジエン | Secretion of exogenous polypeptides by yeast |
| NZ207926A (en) * | 1983-04-25 | 1988-04-29 | Genentech Inc | Use of yeast #a#-factor to assist in expression of proteins heterologus to yeast |
| JPS6041487A (en) * | 1983-04-25 | 1985-03-05 | ジエネンテツク・インコ−ポレイテツド | Use of alpha factor arrangement in yeast development system |
| JPS59227899A (en) * | 1983-05-25 | 1984-12-21 | チロン・コ−ポレイシヨン | Manufacture of growth hormone release factor |
| WO1985004418A1 (en) * | 1984-03-27 | 1985-10-10 | Transgene S.A. | Vectors for the expression of hirudine, transformed cells and process for the preparation of hirudine |
| ATE64956T1 (en) * | 1984-06-14 | 1991-07-15 | Ciba Geigy Ag | PROCESS FOR THE PRODUCTION OF THROMBINE INHIBITORS. |
| DE3429430A1 (en) * | 1984-08-10 | 1986-02-20 | Hoechst Ag, 6230 Frankfurt | GENE TECHNOLOGICAL METHOD FOR PRODUCING HIRUDINE AND MEANS FOR IMPLEMENTING THIS METHOD |
| DE3445517C2 (en) * | 1984-12-13 | 1993-11-18 | Ciba Geigy | DNA sequence coding for a hirudin-like protein and method for producing a hirudin-like protein |
| FR2593518B1 (en) * | 1985-05-02 | 1989-09-08 | Transgene Sa | VECTORS FOR THE EXPRESSION AND SECRETION OF HIRUDIN BY TRANSFORMED YEASTS |
-
1985
- 1985-05-02 FR FR8506672A patent/FR2593518B1/en not_active Expired
-
1986
- 1986-04-30 ZA ZA863261A patent/ZA863261B/en unknown
- 1986-04-30 CA CA000508053A patent/CA1341501C/en not_active Expired - Fee Related
- 1986-04-30 PT PT82490A patent/PT82490B/en unknown
- 1986-05-02 DE DE3650306T patent/DE3650306T2/en not_active Expired - Lifetime
- 1986-05-02 PL PL1986259298A patent/PL155074B1/en unknown
- 1986-05-02 WO PCT/FR1986/000153 patent/WO1986006406A1/en not_active Ceased
- 1986-05-02 IE IE118386A patent/IE67136B1/en not_active IP Right Cessation
- 1986-05-02 HU HU863185A patent/HU202919B/en unknown
- 1986-05-02 AU AU57787/86A patent/AU600667B2/en not_active Expired
- 1986-05-02 EP EP86400961A patent/EP0200655B1/en not_active Expired - Lifetime
- 1986-05-02 MC MC86FR8600153D patent/MC1785A1/en unknown
- 1986-05-02 ES ES555121A patent/ES8703930A1/en not_active Expired
- 1986-05-02 KR KR860700971A patent/KR870700234A/en not_active Ceased
- 1986-05-02 AT AT86400961T patent/ATE121778T1/en not_active IP Right Cessation
- 1986-05-02 JP JP61502537A patent/JP2580141B2/en not_active Expired - Lifetime
- 1986-05-04 CZ CS863217A patent/CZ282928B6/en not_active IP Right Cessation
- 1986-07-10 FR FR868610090A patent/FR2601383B2/en not_active Expired
- 1986-12-19 BG BG077615A patent/BG49717A3/en unknown
- 1986-12-23 FI FI865303A patent/FI104635B/en not_active IP Right Cessation
- 1986-12-30 RU SU864028760A patent/RU1774950C/en active
- 1986-12-30 NO NO865336A patent/NO302375B1/en not_active IP Right Cessation
- 1986-12-30 DK DK198606343A patent/DK174837B1/en not_active IP Right Cessation
-
1996
- 1996-03-26 JP JP8070208A patent/JP2779930B2/en not_active Expired - Lifetime
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BG49717A3 (en) | METHOD OF OBTAINING HIRUDIN | |
| BG47033A3 (en) | Method for preparing of derivatives of imidazolamine | |
| HUT39739A (en) | Process for production of derivatives of 13,3-milbemycin and medical preparatives containing thereof | |
| FR2656337B1 (en) | OXYGEN GENERATING ELECTRODE AND PROCESS FOR ITS PREPARATION. | |
| IT8720059A0 (en) | PROCESS FOR THE PREPARATION OF (2,2)-PARACYCLOPHAN AND ITS DERIVATIVES. | |
| HUT40440A (en) | Process for production of new alpha /-2-i-oxo-2,4,5,6,7a-hexahydro-tieno /3,2-c/-pirid-5-il/ derivatives of phenil acedit acid | |
| HUT47261A (en) | Process for production of new tiasole-derivatives effecting on the cholinerg-system and medical compositions containing these substances | |
| GR860571B (en) | Labdan-derivatives process for their preparation and their use as medicaments | |
| BG35465A3 (en) | Method for preparing derivatives of 1-(cyclohexyl)-4-aryl-4- piperidine carbonic acid | |
| IT8519885A0 (en) | PROCESS FOR THE PRODUCTION OF SUBSTANTIALLY PURE NATURAL EPARAN SULFATE AND DERMATAN SULFATE FOR PHARMACEUTICAL USE. | |
| HUT46907A (en) | Process for production of derivatives of 1,4-dihydropiridine and medical preparatives containing such substances | |
| IT1138511B (en) | PROCEDURE FOR THE PRODUCTION OF A FACTOR VIII THRUST CONCENTRATE (AHF) | |
| ATE70180T1 (en) | AEROSOL FOR NOSE DUSTING OF VITAMIN B 12. | |
| EP0297291A3 (en) | Outer membrane protein f of pseudomonas aeruginosa | |
| FR2607517B2 (en) | VECTORS FOR EXPRESSING HIRUDIN VARIANTS IN YEAST, PROCESS AND PRODUCT OBTAINED | |
| HU911811D0 (en) | Process for the production of acylized alpha, omega-amino-alcoholic derivatives and for using them in pesticide substances | |
| GB2199036B (en) | New furanuronic acid derivatives, process for their production and their use | |
| CS274677B2 (en) | Method of 7-piperazino-6-fluoro-4-oxo-1,4-dihydroquinoline-3-carboxyl acid's derivatives production | |
| ZA855594B (en) | Naphthyl analogs of mevalonolactone and derivatives thereof,processes for their production and their use | |
| ES8700652A1 (en) | Method for producing glyoxylylspermidine and the use thereof for the production of 15-deoxy spergualin-related compounds | |
| DE3171100D1 (en) | Process for separation of products containing propolis and products containing propolis | |
| ZA857721B (en) | Process for treatment of rheumatic diseases | |
| DE3561719D1 (en) | Process for the preparation of symmetrical benzophenones substituted by fluor-containing groups, their use and symmetrical benzophenones substituted by fluor-containing groups | |
| RO87709A (en) | PROCESS FOR PREPARATION OF 1,1-ALCANYL-CARBOXYLATES | |
| CS960486A2 (en) | Method of pregnale-21-acid's 16,17-acetal-substituted derivatives production |